mRNAs corresponding to genes UBA2, GLO1, STATH, and TUFT1, were differentiated in the study samples, irrespective of the stage of ovarian cancer from the control samples, and we decided to focus on them in further analyses. This evidence concerns the gene STATH and ovarian carcinoma.